Workflow
Law
icon
Search documents
DMRC DEADLINE: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Digimarc Corporation Investors to Secure Counsel Before Important July 8 Deadline in Securities Class Action – DMRC
GlobeNewswire News Room· 2025-07-02 16:15
NEW YORK, July 02, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Digimarc Corporation (NASDAQ: DMRC) between May 3, 2024 and February 26, 2025, both dates inclusive (the “Class Period”), of the important July 8, 2025 lead plaintiff deadline. SO WHAT: If you purchased Digimarc securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WH ...
FTRE Shareholders Have the Right to Lead the Fortrea Holdings, Inc. Securities Lawsuit - Contact the DJS Law Group Before the Final Deadline - FTRE
Prnewswire· 2025-07-02 15:12
LOS ANGELES, July 2, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Fortrea Holdings, Inc. ("Fortrea" or "the Company") (NASDAQ: FTRE) for violations of the federal securities laws.Shareholders who purchased the Company's securities between July 3, 2023 and February 28, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before August 1, 2025. DJS Law Group CASE DETAILS:  The complaint alleges that the Company made false and misleading s ...
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Hims & Hers Health
GlobeNewswire News Room· 2025-07-02 15:05
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Hims To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in Hims between April 29, 2025 and June 22, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, July 02, 2025 (GLOBE NEWSWIRE) ...
SRPT Shareholders Have the Right to Lead the Sarepta Therapeutics, Inc. Securities Lawsuit - Contact the DJS Law Group Before the Final Deadline - SRPT
Prnewswire· 2025-07-02 13:24
LOS ANGELES, July 2, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Sarepta Therapeutics, Inc. ("Sarepta" or "the Company") (NASDAQ: SRPT) for violations of the federal securities laws.Shareholders who purchased the Company's securities between June 22, 2023 and June 24, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before August 25, 2025.CASE DETAILS:  The complaint alleges that the Company made false and misleading statements to the ma ...
摩根士丹利:台湾半导体调研观点
摩根· 2025-07-02 03:15
July 1, 2025 03:00 AM GMT Technology - European Semiconductors | Europe Our takes from Taiwan We spent last week meeting contacts in Taiwan and left feeling confident that robust China spending will lift WFE estimates. EDA is attractive, but we acknowledge a wide range of potential outcomes on key debates: China and AI. The latter drives strong growth in the power segment, but a nuanced view is required. Key Takeaways WFE equipment (ASML, ASM, VAT Group) China stays stronger for longer… If there was one con ...
HIMS & HERS HEALTH SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Hims & Hers Health, Inc. - HIMS
GlobeNewswire News Room· 2025-07-02 02:56
Core Viewpoint - Hims & Hers Health, Inc. is facing securities class action lawsuits due to allegations of failing to disclose material information during the class period, which has resulted in significant financial losses for investors [3][4]. Group 1: Legal Actions - Investors have until August 25, 2025, to file lead plaintiff applications in the ongoing securities class action lawsuits against Hims & Hers Health, Inc. for purchases made between April 29, 2025, and June 23, 2025 [1][2]. - The lawsuits are pending in the United States District Court for the Northern District of California, with the first case filed being Sookdeo v. Hims & Hers Health, Inc. [5]. Group 2: Company Issues - Novo Nordisk terminated its partnership with Hims on June 23, 2025, citing violations of laws regarding the sale of compounded drugs and concerns over patient safety due to deceptive marketing practices [4]. - Following the announcement of the partnership termination, Hims' share price dropped by $22.24, or 34.6%, closing at $41.98 per share on June 23, 2025, amid unusually high trading volume [4]. Group 3: Law Firm Background - Kahn Swick & Foti, LLC, the law firm handling the lawsuits, is recognized as one of the top boutique securities litigation firms in the U.S., serving both institutional and retail investors [5].
COMPASS DIVERSIFIED SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Compass Diversified Holdings - CODI
GlobeNewswire News Room· 2025-07-02 02:48
Core Viewpoint - Compass Diversified Holdings is facing securities class action lawsuits due to alleged failure to disclose material information during the class period from March 1, 2023, to May 7, 2025, which has resulted in significant financial losses for investors [1][3]. Group 1: Legal Actions - Investors have until July 8, 2025, to file lead plaintiff applications in the ongoing class action lawsuits against Compass Diversified Holdings [1][2]. - The lawsuits are based on claims that Compass and its executives violated federal securities laws by not disclosing critical information during the specified class period [3]. Group 2: Company Disclosure and Impact - On May 7, 2025, Compass disclosed that its financial statements for fiscal 2024 would require restatement due to an ongoing internal investigation into its subsidiary, Lugano Holding, Inc. [4]. - The investigation revealed irregularities in Lugano's financing, accounting, and inventory practices, leading to the resignation of Lugano's founder and CEO, Moti Ferder [4]. - Following this announcement, Compass' share price dropped approximately 62%, from $17.25 to $6.55 per share within a day [4]. Group 3: Firm Background - Kahn Swick & Foti, LLC is a prominent securities litigation law firm involved in representing investors in cases of corporate fraud and malfeasance [5]. - The firm has been recognized among the top 10 firms nationally based on total settlement value [5].
Loyalty matters, not the oath to Constitution: Ex-DOJ Civil Rights Atty on Trump’s DOJ
MSNBC· 2025-07-02 02:04
It's stunning that 70% of your colleagues like we walking with we just out the door, right? How did that manifest itself uh what you just described this this this lack of interest in enforcing the civil rights laws of of the country uh the lack of interest in standing in between the pillars of the rule of law that touches on every aspect of our lives. How did they do that? What did they say? It is basically like you would bring a case or a matter and they go no we're not doing that or they just tell you dir ...
PETCO ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Petco Health and Wellness Company, Inc. and Encourages Investors to Contact the Firm
GlobeNewswire News Room· 2025-07-02 01:00
Core Viewpoint - A class action lawsuit has been filed against Petco Health and Wellness Company, Inc. for allegedly making materially false and misleading statements regarding its business operations and prospects during the pandemic [1][3]. Summary by Relevant Sections Lawsuit Details - The lawsuit was filed in the United States District Court for the Southern District of California on behalf of all individuals and entities who purchased Petco securities between January 14, 2021, and June 5, 2025 [1]. - Investors have until August 29, 2025, to apply to be appointed as lead plaintiff in the lawsuit [1]. Allegations Against Petco - The lawsuit claims that Petco's pandemic-related growth was unsustainable and that its business model focused on premium pet food was flawed [3]. - It is alleged that the strength of Petco's differentiated product strategy was overstated [3]. - The defendants are accused of downplaying the severity of operational issues and the necessary changes to address them, which could negatively impact Petco's comparable sales [3]. - The lawsuit asserts that Petco's ability to achieve sustainable and profitable growth was overstated [3]. Contact Information - For those affected or seeking more information, contact details for Bragar Eagel & Squire, P.C. are provided, including email and phone number [4][7].
X @The Wall Street Journal
California developers are celebrating the rollback of a landmark environmental law that they say will help clear the way for new housing in a state that has suffered a severe shortage for decades https://t.co/KavmHMvyuW ...